Abstract
Natural killer (NK) cells are crucial for combating the tumor growth and spread of cancer. The receptors which inhibit and activate NK cells coordinate to recognize "self" or "missing-self" to determine whether NK cells should be activated to destroy the targets. NK cells exhibit intrinsic memory to haptens and viral infections despite lacking antigen-specific receptors. A combination of Interleukins may create cytokine-induced memory-like (ML) NK cells that respond more vigorously to tumors and lessen symptoms in cancer patients. Meanwhile, chimeric antigen receptors (CAR) have been utilized to modify NK cells. CAR-NK cells have been tested to be more powerful in treating solid tumors and hematological cancers in both pre-clinical and clinical trials. A few recent studies showed that when ML NK cells are armed with CAR, the resulting CAR-ML-NK cells demonstrated better survival in human xenograft models as well as enhanced responses against cancer cells in vitro and in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have